Zentalis Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Zentalis Pharmaceuticals, Inc. (ZNTL) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.030.480.440.340.05
Short-Term Investments0.340.450.390.280.28
Cash & Short-Term Investments0.370.480.440.340.34
Accounts Receivable0.010.000.010.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.010.000.000.000.01
Total Current Assets0.390.500.450.350.35
Non-Current Assets
Property, Plant & Equipment (Net)0.040.040.050.050.00
Long-Term Investments0.000.000.020.040.00
Goodwill0.000.000.000.000.00
Intangible Assets0.000.000.000.000.01
Other Non-Current Assets0.010.000.000.000.00
Total Non-Current Assets0.040.050.090.100.00
Total Assets0.430.550.540.450.37
Current Liabilities
Accounts Payable0.010.070.060.040.01
Short-Term Debt0.000.000.000.000.00
Accrued Liabilities0.040.050.050.030.02
Other Current Liabilities0.040.010.010.000.00
Total Current Liabilities0.050.070.060.040.03
Non-Current Liabilities
Long-Term Debt0.040.040.050.040.00
Deferred Tax Liabilities0.000.000.000.000.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.040.040.050.050.00
Total Liabilities0.090.110.110.090.03
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-1.05-0.89-0.60-0.36-0.20
Accumulated Other Comprehensive Income0.000.000.000.000.00
Additional Paid-in Capital1.391.321.030.720.00
Minority Interest0.000.000.000.000.00
Shares Outstanding0.070.070.060.050.00
Total Stockholders' Equity0.340.440.430.360.33
Total Liabilities & Equity0.430.550.540.450.00